a decreasing trendp < 2.2×10 −16
The complete monotherapy rates for SGAs without other psychotropic medications in 2001, 2006, 2011, 2016 and 2021 were only 0.7%, 2.7%, 3.5%, 5.0% and 6.3%, respectively ( Table 1 ), with an increasing trend (χ2 = 37.6, df = 1, p = 9.0×10 −10 ). The rates of FGA use in 2001, 2006, 2011, 2016 and 2021 were 85.6%, 77.5%, 70.7%, 65.1% and 54.7%, respectively ( Table 1 and Figure 1A ), with a decreasing trend (χ2 = 190.2, df = 1, p < 2.2×10 −16 ).